Japer Therapeutics Warrants

JSPRW

Market cap $183K

JSPRW Hedge Fund Activity: Q1 2026 in Review

7 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q1 2026, worth a combined $372K — down 51% from $761K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of JSPRW and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $911. The largest seller was Toronto Dominion Bank, cutting an estimated $1.03K.

• 7 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q1 2026, down from 9 in Q4 2025.
• Funds reported $372K of Japer Therapeutics Warrants stock for Q1 2026, down 51% quarter-over-quarter.
• 2 funds opened new Japer Therapeutics Warrants positions in Q1 2026 and 4 closed out, a net change of -2 holders.
• The largest Japer Therapeutics Warrants buyer in Q1 2026 was Susquehanna International Group, an estimated $911 added.
• The largest Japer Therapeutics Warrants seller in Q1 2026 was Toronto Dominion Bank, an estimated $1.03K sold.

Based on aggregated 13F filings for Q1 2026.